Response Genetics (RGDXQ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2014 | 12-2013 | 12-2012 | 12-2011 | 12-2010 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,699 | -8,021 | -7,757 | -5,702 | -4,670 |
| Depreciation Amortization | 885 | 633 | 470 | 367 | 466 |
| Accounts receivable | -7,427 | -3,762 | -2,655 | -613 | -2,976 |
| Accounts payable and accrued liabilities | -85 | 503 | -301 | 245 | 518 |
| Other Working Capital | -8,191 | -2,741 | -2,894 | -1,941 | -3,566 |
| Other Operating Activity | 14,216 | 6,899 | 5,126 | 2,560 | 3,737 |
| Operating Cash Flow | $-14,300 | $-6,489 | $-8,011 | $-5,084 | $-6,492 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -48 | -629 | -426 | -324 | -392 |
| Purchase Sale Intangibles | -54 | -179 | -531 | -67 | N/A |
| Other Investing Activity | -54 | -179 | -531 | -67 | 0 |
| Investing Cash Flow | $-102 | $-808 | $-957 | $-391 | $-392 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 500 | N/A | N/A | 1,000 | N/A |
| Debt Issued | 8,114 | N/A | N/A | N/A | N/A |
| Common Stock Issued | 23 | 6,595 | 16,453 | 2,190 | 3,954 |
| Other Financing Activity | -169 | -188 | -148 | -61 | 0 |
| Financing Cash Flow | $8,469 | $6,407 | $16,305 | $3,129 | $3,954 |
| Exchange Rate Effect | 8 | -4 | 4 | -73 | -9 |
| Beginning Cash Position | 8,149 | 9,042 | 1,700 | 4,120 | 7,058 |
| End Cash Position | 2,223 | 8,149 | 9,042 | 1,700 | 4,120 |
| Net Cash Flow | $-5,926 | $-893 | $7,341 | $-2,420 | $-2,938 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,300 | -6,489 | -8,011 | -5,084 | -6,492 |
| Capital Expenditure | -50 | -629 | -426 | -324 | -392 |
| Free Cash Flow | -14,350 | -7,117 | -8,437 | -5,408 | -6,883 |